Infinity Pharma (INFI) Tops Q3 EPS by 1c

Infinity Pharma (NASDAQ: INFI) reported Q3 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $0 versus the consensus estimate of $520 thousand.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22